Risk of Cerebrovascular Accident and Major Adverse Cardiovascular Events associated with Risankizumab for Psoriasis
=============

<img src="https://img.shields.io/badge/Study%20Status-Repo%20Created-lightgray.svg" alt="Study Status: Repo Created">

- Analytics use case(s): **-**
- Study type: Population Estimation: Comparative Safety
- Tags: **-**
- Study lead: Zenas Yiu
- Study lead forums tag: **[[Zenas Yiu]](https://forums.ohdsi.org/u/zenasyiu)**
- Study start date: **-**
- Study end date: **-**
- Protocol: **-**
- Publications: **-**
- Results explorer: **-**

[Description (single paragraph)]

[You can add other text at this point]
